Stevanato Group (NYSE:STVN) today announced a collaboration with Recipharm to manufacture pre-fillable syringes for soft mist inhalers.
Piombino Dese, Italy-based Stevanato Group plans to lend manufacturing experience to support production of the syringes. As part of the collaboration, it intends to provide and manufacture its Alba glass pre-fillable syringe. Stevanato Group will assemble Alba with the integrated spray module (ISMTM) of Recipharm’s soft mist inhaler. Together, this creates the “pre-filled syringe inhaler” (PFSITM).
In the partnership, Stevanato Group takes responsibility for the complete primary drug package. Recipharm’s focus centers around the design and manufacture of the spray technology, the inhalation device and the fill/finish effort.
Get the full story at our sister site, Drug Delivery Business News.